South America Amniotic Products Market Forecast to 2028 – COVID

South America Amniotic Products Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type [Amniotic Membranes (Cryopreserved Amniotic Membranes and Dehydrated Amniotic Membranes) and Amniotic Suspensions], Application (Wound Care, Orthopedics, Ophthalmology, and Other Applications), and End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Other End Users)

Report Code : BMIRE00026295 | Region : LAMEA | Industry : Pharmaceuticals | Published Date : 25/Sep/2022

The SAM amniotic products market is expected to grow from US$ 71.16 million in 2022 to US$ 111.62 million by 2028; it is estimated to grow at a CAGR of 7.8% from 2022 to 2028.

According to a 2018 retrospective examination of Medicare users, 8.2 million persons suffered wounds that were infected or not. The cost of acute and chronic wound treatments was estimated to cost between US$ 28.1 billion and US$ 96.8 billion by Medicare. Surgical wounds were the most expensive, followed by diabetic foot ulcers, with outpatient wound care costs higher than inpatient wound care. Traumatic wounds are a significant clinical, social, and economic burden because of the rising healthcare expenditures, an aging population, identification of difficult-to-treat infection risks such as biofilms, and the global hazard of diabetes and obesity. Traumatic wounds are those that have not proceeded through the normal healing process and have been open for longer than a month. Traumatic wounds have a variety of causes, all of which place a strain on the healthcare system. Diabetic and obese patients are at a higher risk of getting chronic wounds. Most persons who have a long-term open wound also have additional serious health problems. Comorbidity refers to the existence of multiple chronic diseases at the same time. Comorbidities complicate chronic wounds, making it difficult to follow chronic wounds as a disease in and of itself. In comparison to the overall burden of chronic wounds as a health care concern, research funding dedicated to studying chronic wounds is disproportionately low. Wound healing using amniotic membrane grafts has some therapeutic potential. Early use of an amniotic membrane for ulcers, burns, and cutaneous injuries proved therapeutic. Therefore, an increasing number of traumatic wounds is boosting the amniotic product market.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the SAM amniotic products market . The SAM amniotic products market is expected to grow at a good CAGR during the forecast period.

SAM Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

SAM Amniotic Products Market Segmentation

The SAM amniotic products market is bifurcated based on type, application, end user and country. Based on type, the market is segmented into amniotic membranes, and amniotic suspensions. The amniotic membranes segment dominated the market in 2022 and is expected to be fastest growing during forecast period. Based on application, the market is segmented into wound care, orthopedics, ophthalmology, and other applications. The wound care segment dominated the market in 2022 and orthopedics segment is expected to be fastest growing during forecast period. Based on end user, the market is segmented into hospitals and clinics, ambulatory surgical centers, and other end users. The hospitals and clinics segment dominated the market in 2022 and ambulatory surgical centers segment is expected to be fastest growing during forecast period. Based on country, the SAM amniotic products market is segmented into the Brazil, Argentina, and Rest of SAM.

Integra LifeSciences; Katena Products. Inc.; MiMedx; NuVision Biotherapies Ltd; Organogenesis, Inc.; Sanuwave and Sanuwave Health, Inc.; Smith & Nephew; and Stryker are among the leading companies in the SAM amniotic products market.

At 7.8% CAGR, the SAM Amniotic Product Market is speculated to be worth US$ 582.01 million by 2028, says The Insight Partners

According to The Insight Partners’ research, the SAM amniotic product market was valued at US$ 71.16 million in 2022 and is expected to reach US$ 111.62 million by 2028, registering an annual growth rate of 7.8% from 2022 to 2028. Rising incidence of burn injuries and increasing number of traumatic wounds are the critical factors attributed to the market expansion.

Due to the high prevalence of burn wounds, demand for wound care biologics, such as amniotic membranes, has increased significantly. In 2019, a total of 8,378,122 new cases of burns were identified (95% UI, 10,363,109–6,531,887 cases). Burn fatality rates have been declining in many high-income nations, but child burn deaths are now approximately 7 times greater in low- and middle-income countries than in high-income countries. From 1990 to 2019, the burden of burns declined progressively and was thought to be reduced in most regions. Moreover, according to the Children's Burn Trust and the British Burn Association, 625 children are admitted to an NHS Burns Service each month due to burn or scald injuries. In 2017, the NHS's burns and scalds services treated more than 15,000 patients with these injuries, with a total cost of more than US$ 24.94 million (i.e., GBP 20 million). More than 40 of the total burn treatment admissions in 2017 were classified as extremely serious, with treatment procedures costing more than US$ 118,455.50 (GBP 95,000) per person. Biologic materials are now used in various surgical procedures thanks to recent tissue harvesting, screening, and banking advancements. Burns, nerve regeneration, soft tissue reconstructive surgeries, ophthalmic surgeries, and diabetic foot ulcer surgeries are just a few of the applications for amniotic membranes. Amniotic membrane has been demonstrated to improve healing rates, reduce infection rates, shorten hospital stays, and reduce the number of dressing changes required in burn patients. Therefore, it has a lot of scopes to improve outcomes and save money. The amniotic membrane is helpful in chronic wounds, such as diabetic foot ulcers, and it holds tremendous potential for the treatment of donor skin graft sites, wounds treated with skin grafts, and partial thickness burns. Thus, increasing burn cases are driving the amniotic product market.

On the contrary, complications and limitations associated with the use of amniotic membranes secret hurdles the growth of SAM amniotic product market.

Based on type, the SAM amniotic product market is segmented into amniotic membranes and amniotic suspensions. The amniotic membranes segment held 84.2% market share in 2022, amassing US$ 59.93 million. It is projected to garner US$ 96.71 million by 2028 to expand at 8.3% CAGR during 2022–2028.

Based on application, the SAM amniotic product market is segmented into wound care, orthopedics, ophthalmology, and other applications. The periodontics segment held 39.2% market share in 2022, amassing US$ 27.87 million. It is projected to garner US$ 42.99 million by 2028 to expand at 7.5% CAGR during 2022–2028.

Based on end user, the SAM amniotic product market is segmented into hospitals and clinics, ambulatory surgical centers, and other end users. The hospitals and clinics segment held 49.7% market share in 2022, amassing US$ 35.35 million. It is projected to garner US$ 55.96 million by 2028 to expand at 8.0% CAGR during 2022–2028.

Based on country, the SAM amniotic product market is segmented into brazil, Argentina, and Rest of SAM. Our regional analysis states that Brazil captured 57.9% market share in 2022. It was assessed at US$ 41.22 million in 2022 and is likely to hit US$ 65.55 million by 2028, exhibiting a CAGR of 8.0% during the forecast period.

Key players dominating the SAM amniotic product market are Integra LifeSciences; Katena Products. Inc.; MiMedx; NuVision Biotherapies Ltd; Organogenesis, Inc.; Sanuwave and Sanuwave Health, Inc.; Smith & Nephew; and Stryker among others.

• In Feb 2021, Stryker completed the acquisition of Wright Medical, Inc. a global medical device company focused on extremities and biologics. This acquisition strengthens global market position in trauma and extremities, providing significant opportunities to drive innovation and reach more patients.

• In Jan 2020, Integra LifeSciences Holdings Corporation entered into a definitive agreement to acquire ACell, Inc. (ACell) for a $300 million cash upfront payment at closing subject to customary purchase price adjustments and cash payments of up to an additional $100 million upon achievement of certain revenue growth milestones. ACell is an innovative regenerative medicine company with a product portfolio based on MatriStem UBM, a proprietary porcine bladder matrix platform technology. The transaction is expected to close in the first quarter of 2021, subject to the satisfaction of customary conditions, including regulatory approvals. The acquisition of ACell is the next step in expanding Integras' Orthopedics and Tissue Technologies (OTT) segment. Following the completion of the previously announced sale of Integras' orthopedic business, which is expected to occur in early January, OTT will be referred to as the Tissue Technologies segment.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 SAM Amniotic Products Market – By Type

1.3.2 SAM Amniotic Products Market – By Application

1.3.3 SAM Amniotic Products Market – By End User

1.3.4 SAM Amniotic Products Market – By Country

2. SAM Amniotic Products Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. SAM Amniotic Products Market – Market Landscape

4.1 Overview

4.2 SAM PEST Analysis

4.3 Experts Opinion

5. Amniotic Products Market– Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Incidence of Burn Injuries

5.1.2 Increasing Number of Traumatic Wounds

5.2 Market Restraints

5.2.1 Complications and Limitations Associated with Use of Amniotic Membranes

5.3 Market Opportunities

5.3.1 Implementation of the 21st Century Cures Act

5.4 Future Trends

5.4.1 Increasing Demand for Stem Cell Research and Regenerative Medicine

5.5 Impact Analysis

6. Amniotic Products Market– SAM Analysis

6.1 SAM Amniotic Products Market Revenue Forecast and Analysis

6.1.1 Overview

7. SAM Amniotic Products Market Revenue and Forecast to 2028 – by Type

7.1 Overview

7.2 SAM Amniotic Products Market, by Type, 2022 & 2028 (%)

7.3 Amniotic Membranes

7.3.1 Overview

7.3.2 Amniotic Membranes: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

7.3.2.1 Cryopreserved Amniotic Membranes

7.3.2.1.1 Cryopreserved Amniotic Membranes: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

7.3.2.2 Dehydrated Amniotic Membranes

7.3.2.2.1 Dehydrated Amniotic Membranes: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

7.4 Amniotic Suspensions

7.4.1 Overview

7.4.2 Amniotic Suspensions: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

8. SAM Amniotic Products Market Revenue and Forecast to 2028 – by Application

8.1 Overview

8.2 SAM Amniotic Products Market Share by Application - 2022 & 2028 (%)

8.3 Wound Care

8.3.1 Overview

8.3.2 Wound Care: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

8.4 Orthopedics

8.4.1 Overview

8.4.2 Orthopedics: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

8.5 Ophthalmology

8.5.1 Overview

8.5.2 Ophthalmology: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

8.6 Other Applications

8.6.1 Overview

8.6.2 Other Applications: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

9. SAM Amniotic Products Market Revenue and Forecast to 2028 – by End User

9.1 Overview

9.2 SAM Amniotic Products Market Share by End User - 2022 & 2028 (%)

9.3 Hospitals and Clinics

9.3.1 Overview

9.3.2 Hospitals and Clinics: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

9.4 Ambulatory Surgical Centers

9.4.1 Overview

9.4.2 Ambulatory Surgical Centers: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

9.5 Other End Users

9.5.1 Overview

9.5.2 Other End Users: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

10. SAM Amniotic Products Market Revenue and Forecast to 2028 – by Country

10.1 Overview

10.1.1 SAM: Amniotic Products Market – Revenue and Forecast to 2028 (USD Million)

10.1.2 SAM: Amniotic Products Market, By Type, 2019–2028 (USD Million)

10.1.2.1 SAM Amniotic Products Market in Amniotic Membranes, by Type– Revenue and Forecast to 2028 (USD Million)

10.1.3 SAM: Amniotic Products Market, By Application, 2019–2028 (USD Million)

10.1.4 SAM: Amniotic Products Market, by End User, 2019–2028 (USD Million)

10.1.5 SAM: Amniotic Products Market, by Country, 2022 & 2028 (%)

10.1.5.1 Brazil: Amniotic Products Market – Revenue and Forecast to 2028 (USD Million)

10.1.5.1.1 Brazil: Amniotic Products Market – Revenue and Forecast to 2028 (USD Million)

10.1.5.1.2 Brazil: Amniotic Products Market, By Type, 2019–2028 (USD Million)

10.1.5.1.2.1 Brazil Amniotic Products Market in Amniotic Membranes, by Type– Revenue and Forecast to 2028 (USD Million)

10.1.5.1.3 Brazil: Amniotic Products Market, By Application, 2019–2028 (USD Million)

10.1.5.1.4 Brazil: Amniotic Products Market, by End User, 2019–2028 (USD Million)

10.1.5.2 Argentina: Amniotic Products Market – Revenue and Forecast to 2028 (USD Million)

10.1.5.2.1 Argentina: Amniotic Products Market – Revenue and Forecast to 2028 (USD Million)

10.1.5.2.2 Argentina: ? Amniotic Products Market, By Type, 2019–2028 (USD Million)

10.1.5.2.2.1 Argentina Amniotic Products Market in Amniotic Membranes, by Type– Revenue and Forecast to 2028 (USD Million)

10.1.5.2.3 Argentina: Amniotic Products Market, By Application, 2019–2028 (USD Million)

10.1.5.2.4 Argentina: Amniotic Products Market, by End User, 2019–2028 (USD Million)

10.1.5.3 Rest of SAM: Amniotic Products Market – Revenue and Forecast to 2028 (USD Million)

10.1.5.3.1 Rest of SAM: Amniotic Products Market – Revenue and Forecast to 2028 (USD Million)

10.1.5.3.2 Rest of SAM: Amniotic Products Market, By Type, 2019–2028 (USD Million)

10.1.5.3.2.1 Rest of SAM Amniotic Products Market in Amniotic Membranes, by Type– Revenue and Forecast to 2028 (USD Million)

10.1.5.3.3 Rest of SAM: Amniotic Products Market, By Application, 2019–2028 (USD Million)

10.1.5.3.4 Rest of SAM: Amniotic Products Market, by End User, 2019–2028 (USD Million)

11. Amniotic Products Market–Industry Landscape

11.1 Overview

11.2 Organic Developments

11.2.1 Overview

11.3 Inorganic Developments

11.3.1 Overview

12. Company Profiles

12.1 MiMedx

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Smith & Nephew

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Integra LifeSciences

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Stryker

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Katena Products. Inc.

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 NuVision Biotherapies Ltd

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Organogenesis, Inc.

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Sanuwave and Sanuwave Health, Inc.

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES.

Table 1.             SAM Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

Table 2.             SAM: Amniotic Products Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 3.             SAM Amniotic Products Market in Amniotic Membranes, by Type – Revenue and Forecast to 2028 (USD Million)

Table 4.             SAM: Amniotic Products Market, By Application – Revenue and Forecast to 2028 (USD Million)

Table 5.             SAM: Amniotic Products Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 6.             Brazil: Amniotic Products Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 7.             Brazil Amniotic Products Market in Amniotic Membranes, by Type – Revenue and Forecast to 2028 (USD Million)

Table 8.             Brazil: Amniotic Products Market, By Application – Revenue and Forecast to 2028 (USD Million)

Table 9.             Brazil: Amniotic Products Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 10.          Argentina: Amniotic Products Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 11.          Argentina Amniotic Products Market in Amniotic Membranes, by Type – Revenue and Forecast to 2028 (USD Million)

Table 12.          Argentina: Amniotic Products Market, By Application – Revenue and Forecast to 2028 (USD Million)

Table 13.          Argentina: Amniotic Products Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 14.          Rest of SAM: Amniotic Products Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 15.          Rest of SAM Amniotic Products Market in Amniotic Membranes, by Type – Revenue and Forecast to 2028 (USD Million)

Table 16.          Rest of SAM: Amniotic Products Market, By Application – Revenue and Forecast to 2028 (USD Million)

Table 17.          Rest of SAM: Amniotic Products Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 18.          Organic Developments Done by Companies

Table 19.          Inorganic Developments Done by Companies

Table 20.          Glossary of Terms, SAM Amniotic Products Market

LIST OF FIGURES.

Figure 1.           SAM Amniotic Products Market Segmentation

Figure 2.           SAM Amniotic Products Market – By Country

Figure 3.           SAM Amniotic Products Market Overview

Figure 4.           Amniotic Membranes Held Largest Share by Type of Amniotic Products Market

Figure 5.           Brazil to Show Significant Growth During Forecast Period

Figure 6.           SAM: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           SAM Amniotic Products Market Impact Analysis of Drivers and Restraints

Figure 9.           SAM Amniotic Products Market– Revenue Forecast and Analysis – 2020 - 2028

Figure 10.        SAM Amniotic Products Market, by Type, 2022 & 2028 (%)

Figure 11.        SAM Amniotic Membranes: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

Figure 12.        SAM Cryopreserved Amniotic Membranes: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

Figure 13.        SAM Dehydrated Amniotic Membranes: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

Figure 14.        SAM Amniotic Suspensions: Amniotic Products Market Revenue and Forecast to 2028 (US$ Million)

Figure 15.        SAM Amniotic Products Market Share by Application - 2022 & 2028 (%)

Figure 16.        SAM Wound Care: Amniotic Products Market Revenue and Forecast To 2028 (US$ Million)

Figure 17.        SAM Orthopedics: Amniotic Products Market Revenue and Forecast To 2028 (US$ Million)

Figure 18.        SAM Ophthalmology: Amniotic Products Market Revenue and Forecast To 2028 (US$ Million)

Figure 19.        SAM Other Applications: Amniotic Products Market Revenue and Forecast To 2028 (US$ Million)

Figure 20.        SAM Amniotic Products Market Share by End User - 2022 & 2028 (%)

Figure 21.        SAM Hospitals and Clinics: Amniotic Products Market Revenue and Forecast To 2028 (US$ Million)

Figure 22.        SAM Ambulatory Surgical Centers: Amniotic Products Market Revenue and Forecast To 2028 (US$ Million)

Figure 23.        SAM Other End Users: Amniotic Products Market Revenue and Forecast To 2028 (US$ Million)

Figure 24.        SAM: Amniotic Products Market, by Key Country – Revenue (2022) (USD Million)

Figure 25.        SAM Amniotic Products Market Revenue and Forecast to 2028 (USD Million)

Figure 26.        SAM: Amniotic Products Market, by Country, 2022 & 2028 (%)

Figure 27.        Brazil: Amniotic Products Market – Revenue and Forecast to 2028 (USD Million)

Figure 28.        Argentina: Amniotic Products Market – Revenue and Forecast to 2028 (USD Million)

Figure 29.        Rest of SAM: Amniotic Products Market – Revenue and Forecast to 2028 (USD Million)

The List of Companies - South America Amniotic Products Market

● Integra LifeSciences

● Katena Products. Inc.

● MiMedx

● NuVision Biotherapies Ltd

● Organogenesis, Inc.

● Sanuwave and Sanuwave Health, Inc.

● Smith & Nephew

● Stryker

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the SAM amniotic products market.

● Highlights key business priorities in order to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in the SAM amniotic products market, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth SAM market trends and outlook coupled with the factors driving the amniotic products market, as well as those hindering it

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

TOP